All News CH Biotech R&D Co., Ltd.

Equities

6534

TW0006534001

End-of-day quote Taiwan S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
86.8 ^TWD	+1.17%		-1.70%	+7.83%

21/05	Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members	CI
21/05	CH Biotech R&D Co., Ltd. Announces Audit Committee Changes	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ch Biotech R&D Co., Ltd. Approves the Appointments of the 4th Remuneration Committee Members	21/05	CI
CH Biotech R&D Co., Ltd. Announces Audit Committee Changes	21/05	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
CH Biotech R&D Co., Ltd.(TWSE:6534) added to Taiwan TAIEX Index	07/03	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Second Half of 2023, Payable on April 12, 2024	27/02	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the First Half Ended June 30, 2023, Payable on October 18, 2023	08/23/08	CI
CH Biotech R&D Co., Ltd. Appoints Robert James Christopher Clayton as Institutional Director Representative	24/23/24	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/23/21	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	21/23/21	CI
CH Biotech R&D Co., Ltd. Announces Resignation of Brent Randall Smith as Natural-Person Director	12/23/12	CI
CH Biotech R&D Co., Ltd. Announces CHB Resignation of Brent Randall Smith as Natural-Person Director	02/23/02	CI
CH Biotech R&D Co., Ltd. Approves Cash Dividend for the Year Ended December 31, 2022, Payable on April 10, 2023	21/23/21	CI
CH Biotech R&D Co., Ltd.(TPEX:6534) added to S&P Global BMI Index	19/22/19	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	15/22/15	CI
CH Biotech R&D Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	02/22/02	CI
Ch Biotech R&D Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	14/21/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News CH Biotech R&D Co., Ltd.

Equities

6534

TW0006534001

All News

Filters